PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
IntroductionImmune checkpoint blockade (ICB) immunotherapy has revolutionized cancer treatment, demonstrating exceptional clinical responses in a wide range of cancers. Despite the success, a significant proportion of patients still fail to respond, hi…